Compugen to Present UnigenX™ Platform at the 18th Annual PEGS Europe Summit
HOLON, Israel, Nov. 10, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI, today announced an oral presentation at the 18th Annual Protein and Antibody Engineering...